Document is current

Any future updates will be listed below

Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3

Crossref DOI link: https://doi.org/10.1186/s13075-017-1490-y

Published Online: 2017-12-22

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark